IgA nephropathy at two score and one.
暂无分享,去创建一个
[1] C. Ponticelli,et al. Kidney transplantation in patients with IgA mesangial glomerulonephritis. , 2001, Kidney international.
[2] D. Centonze,et al. Urine protein profile of IgA nephropathy patients may predict the response to ACE‐inhibitor therapy , 2008, Proteomics.
[3] F. Eitner,et al. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol. , 2008, Journal of nephrology.
[4] I. Roberts,et al. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. , 2002, Journal of the American Society of Nephrology : JASN.
[5] J. Barratt,et al. B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy. , 2008, Kidney international.
[6] Kunihiko Kobayashi,et al. Degalactosylated and/or Denatured IgA, but Not Native IgA in Any Form, Bind to Mannose-Binding Lectin1 , 2006, The Journal of Immunology.
[7] Yusuke Suzuki,et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. , 2009, The Journal of clinical investigation.
[8] B. Julian,et al. Role of Aberrant Glycosylation of IgA1 Molecules in the Pathogenesis of IgA Nephropathy , 2008, Kidney and Blood Pressure Research.
[9] M. Hristov,et al. No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy patients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[10] G. Signoriello,et al. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[11] Sandrine Florquin,et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. , 2009, Kidney international.
[12] L. Peruzzi,et al. Serum IgA and macromolecular IgA reacting with mesangial matrix components. , 1993, Contributions to nephrology.
[13] Claudio Pozzi,et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. , 2004, Journal of the American Society of Nephrology : JASN.
[14] Fernand,et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. , 2009, Kidney international.
[15] L. Peruzzi,et al. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. , 2007, Journal of the American Society of Nephrology : JASN.
[16] Y. Tomino. IgA nephropathy: lessons from an animal model, the ddY mouse. , 2008, Journal of nephrology.
[17] J. Barratt,et al. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. , 1999, Journal of the American Society of Nephrology : JASN.
[18] K. Kitamura,et al. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[19] R. Lifton,et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. , 2008, Journal of the American Society of Nephrology : JASN.
[20] Y. Hiki,et al. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 1998, Journal of the American Society of Nephrology : JASN.
[21] I. Narita,et al. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. , 2003, Kidney international.
[22] M. Kerr,et al. The structure and function of human IgA. , 1990, The Biochemical journal.
[23] T. Taguchi,et al. Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.
[24] G. D'Amico,et al. The commonest glomerulonephritis in the world: IgA nephropathy. , 1987, The Quarterly journal of medicine.
[25] F. Lai,et al. Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy. , 2008, American journal of physiology. Renal physiology.
[26] R. Monteiro. Pathogenic role of IgA receptors in IgA nephropathy. , 2007, Contributions to nephrology.
[27] E. Morales,et al. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. , 2003, Journal of the American Society of Nephrology : JASN.
[28] G. Alarcón,et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. , 2008, The Journal of clinical investigation.
[29] J. D. de Fijter,et al. GMP-17-positive T-lymphocytes in renal tubules predict progression in early stages of IgA nephropathy. , 2008, Kidney international.
[30] M. Rastaldi,et al. Demonstration of secretory IgA in kidneys of patients with IgA nephropathy. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[31] K. Kimura,et al. Prediction of corticosteroid responsiveness based on fibroblast-specific protein 1 (FSP1) in patients with IgA nephropathy. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[32] Peggo K. W. Lam,et al. Recurrent IgA nephropathy in renal transplant allografts. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[33] Y. Yamaguchi,et al. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. , 2003, Kidney international.
[34] L. Peruzzi,et al. Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation , 2007, Clinical transplantation.
[35] Hong Zhang,et al. Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. , 2007, Kidney international.